Sanofi-Aventis (SNY) and Accomplia - Potential Blockbuster Drug

Exciting news this morning from one of my favorite pharmaceutical companies, Sanofi-Aventis (SNY). Clinical data show that the "Acomplia pill can significantly improve blood sugar levels in patients with type 2 diabetes while also reducing their weight." The potential of this weight-loss medication is huge. See http://biz.yahoo.com/rb/061205/sanofiaventis_acomplia.html?.v=1. 

With its low P/E, good dividend, international revenue streams (good with a weakening dollar), and strong pipeline, SNY is an outstanding investment and seems quite cheap at the moment. Get it at $44 before it moves to $50 on the next bit of news. 

links: digg this    del.icio.us    technorati    reddit